Logo image of DFFN

DIFFUSION PHARMACEUTICALS IN (DFFN) Stock Analyst Ratings

USA - NASDAQ:DFFN - US2537484048 - Common Stock

4.4 USD
+0.46 (+11.68%)
Last: 8/16/2023, 8:00:02 PM
4.46 USD
+0.06 (+1.36%)
After Hours: 8/16/2023, 8:00:02 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to DFFN. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 40.8. This target is 827.27% above the current price.
DFFN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DFFN.
In the previous month the buy percentage consensus was at a similar level.
DFFN was analyzed by 7 analysts. More opinions would make the average more meaningful.

Related screens

DFFN Historical Analyst RatingsDFFN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -61 -55 -49 -43 -37 -31 -25 -19 -13 -7 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 4.4040.4040.8040.8042.00 - 818.18% 827.27% 827.27% 854.55%

Related screens

DFFN Current Analyst RatingDFFN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2022-08-16 HC Wainwright & Co. Upgrade Neutral -> Buy

DIFFUSION PHARMACEUTICALS IN / DFFN FAQ

What do analysts expect the price target to be for DIFFUSION PHARMACEUTICALS IN (DFFN)?

7 analysts have analysed DFFN and the average price target is 40.8 USD. This implies a price increase of 827.27% is expected in the next year compared to the current price of 4.4.


How do analysts rate DIFFUSION PHARMACEUTICALS IN (DFFN)?

The consensus rating for DIFFUSION PHARMACEUTICALS IN (DFFN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.